Engineered virus teams up with drug to fight deadly brain cancer
NCT ID NCT05084430
Summary
This study is testing a new combination treatment for aggressive brain cancers like glioblastoma. It combines a genetically engineered virus designed to attack cancer cells with an immunotherapy drug that helps the immune system fight the tumor. The trial aims to find a safe and effective dose for patients with newly diagnosed or recurring tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35294, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.